Compare NUE & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUE | EW |
|---|---|---|
| Founded | 1905 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.7B | 49.9B |
| IPO Year | 1994 | 1999 |
| Metric | NUE | EW |
|---|---|---|
| Price | $218.26 | $92.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 21 |
| Target Price | ★ $209.60 | $96.37 |
| AVG Volume (30 Days) | 1.7M | ★ 4.3M |
| Earning Date | 04-27-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.23 | 0.66 |
| Revenue | N/A | ★ $6,067,600,000.00 |
| Revenue This Year | $12.07 | $13.39 |
| Revenue Next Year | $4.14 | $9.81 |
| P/E Ratio | ★ $68.95 | $137.05 |
| Revenue Growth | N/A | ★ 11.55 |
| 52 Week Low | $131.32 | $72.30 |
| 52 Week High | $270.90 | $92.88 |
| Indicator | NUE | EW |
|---|---|---|
| Relative Strength Index (RSI) | 33.75 | 65.82 |
| Support Level | $159.45 | $82.02 |
| Resistance Level | $235.45 | N/A |
| Average True Range (ATR) | 8.18 | 2.29 |
| MACD | -5.05 | 0.37 |
| Stochastic Oscillator | 6.61 | 93.20 |
Nucor Corp manufactures steel and steel products. The company's reportable segments are steel mills, steel products, and raw materials. The majority of its revenue is derived from the steel mills segment, which is engaged in producing sheet steel (hot-rolled, cold-rolled, and galvanized), plate steel, structural steel (wide-flange beams, beam blanks, H-piling, and sheet piling), and bar steel products. Nucor manufactures steel principally from scrap steel and scrap steel substitutes using electric arc furnaces (EAFs), along with continuous casting and automated rolling mills. The steel mills segment sells its products mainly to steel service centers, fabricators, and manufacturers located in the United States, Canada, and Mexico.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.